Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
16.73 USD | -1.99% | -2.68% | -46.73% |
Kurzporträt
Mitarbeiterzahl: 598
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Innovative Medicines
100,0
%
| 517 | 100,0 % | 726 | 100,0 % | +40.45% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 517 | 100,0 % | 726 | 100,0 % | +40.45% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Stephen Davis
CEO | Chief Executive Officer | 63 | 15.07.14 |
Mark Schneyer
DFI | Director of Finance/CFO | 50 | 28.05.20 |
Sanjeev Pathak
CTO | Chief Tech/Sci/R&D Officer | - | 01.03.21 |
Chief Tech/Sci/R&D Officer | 61 | 09.01.23 | |
Brendan Teehan
COO | Chief Operating Officer | 56 | 01.07.18 |
Ponni Subbiah
CTO | Chief Tech/Sci/R&D Officer | - | 01.10.19 |
Benir Ruano
CTO | Chief Tech/Sci/R&D Officer | - | 01.11.22 |
- | - | ||
Holly Valdiviez
SAM | Sales & Marketing | - | 01.04.22 |
Rob Ackles
HRO | Human Resources Officer | - | 01.01.14 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 11.12.15 |
Edmund Harrigan
BRD | Director/Board Member | 71 | 25.11.15 |
Stephen Davis
CEO | Chief Executive Officer | 63 | 15.07.14 |
Don Soland
BRD | Director/Board Member | 65 | 20.03.15 |
Laura Brege
BRD | Director/Board Member | 66 | 01.05.08 |
Stephen Biggar
CHM | Chairman | 53 | 22.01.13 |
James Daly
BRD | Director/Board Member | 63 | 11.01.16 |
Director/Board Member | 66 | 29.09.20 | |
Adora Ndu
BRD | Director/Board Member | 43 | 10.10.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 164 771 521 | 163 859 371 ( 99,45 %) | 0 | 99,45 % |
Unternehmenskontakt
ACADIA Pharmaceuticals, Inc.
12830 El Camino Real Suite 400
92130-3331, San Diego
+(858) 558-2871
http://www.acadia.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-46.73% | 2.81 Mrd. | |
-1.92% | 41.35 Mrd. | |
+42.15% | 40.38 Mrd. | |
+1.28% | 39.05 Mrd. | |
-14.19% | 26.67 Mrd. | |
+2.02% | 24.07 Mrd. | |
-24.47% | 18.36 Mrd. | |
-4.07% | 11.68 Mrd. | |
+21.23% | 11.6 Mrd. | |
+7.77% | 11.15 Mrd. |
- Börse
- Aktien
- 603035 Aktie
- Unternehmen ACADIA Pharmaceuticals Inc.